Correlation Between Bristol Myers and Agenus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Agenus Inc, you can compare the effects of market volatilities on Bristol Myers and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Agenus.

Diversification Opportunities for Bristol Myers and Agenus

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bristol and Agenus is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Bristol Myers i.e., Bristol Myers and Agenus go up and down completely randomly.

Pair Corralation between Bristol Myers and Agenus

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.28 times more return on investment than Agenus. However, Bristol Myers Squibb is 3.54 times less risky than Agenus. It trades about -0.01 of its potential returns per unit of risk. Agenus Inc is currently generating about -0.01 per unit of risk. If you would invest  5,857  in Bristol Myers Squibb on November 28, 2024 and sell it today you would lose (69.00) from holding Bristol Myers Squibb or give up 1.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Agenus Inc

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Agenus Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Agenus is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Bristol Myers and Agenus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Agenus

The main advantage of trading using opposite Bristol Myers and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.
The idea behind Bristol Myers Squibb and Agenus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets